Patents

A synergistic composition useful for hepatocurative action against cyp 450 bio-activation mediated hepatotoxicity, induced by one or more drugs

The present invention relates to a composition useful for Hepatocurative effect against CYP 450 bio-activation Hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and use of treating drug induced Hepatotoxicity.

Filing Date: 05-08-2003

Issue Date: 25-04-2008

Patent No: IN217746 [India]

Application No: 1232/DELNP/2003

Inventor(s): Rakesh Kamal Johri; Sheikh Tasaduq Abdullah; Kuldip Singh; Devinder Kumar Gupta; Bal Krishan Kapahi; Dilip Manikrao Mohdhe; Satinder Mohan Jain; Om Parkash Suri; Kasturi Lal Badi; Ghulam Nabi Qazi

Licensing Option: Laboratory willing to jointly develop technology with industrial partner.

Implementing institute: CSIR-Indian Institute of Integrative Medicine [CSIR-IIIM]

Funding agency: Council of Scientific and Industrial Research (CSIR)

IPC Classification: A61K 35/78

US9868695: 10-substituted colchicinoids as potent anticancer agents

US9518033 (4e)-4-(4-Substituted Benzylideneamino)-2,3-Dihydro-3-Substituted-2-Thioxothiazole-5-Carbonitriles As a2ar Antagonist And Process For Preparation Thereof

US9273039: Synthesis of new benzothiazole derivatives as potential anti-tubercular agents

US9127080: Protein-coding RNA to correct mitochondrial dysfunction

Search form